AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,816 | -32.8% | 2,270 | -38.0% | 0.00% | – |
| Q2 2023 | $170,932 | +38.5% | 3,661 | +13.5% | 0.00% | – |
| Q1 2023 | $123,388 | -69.7% | 3,225 | -56.6% | 0.00% | -100.0% |
| Q4 2022 | $407,328 | +115.5% | 7,433 | +34.1% | 0.00% | – |
| Q3 2022 | $189,000 | +800.0% | 5,541 | +145.7% | 0.00% | – |
| Q2 2022 | $21,000 | +5.0% | 2,255 | +63.9% | 0.00% | – |
| Q1 2022 | $20,000 | -13.0% | 1,376 | +25.1% | 0.00% | – |
| Q4 2021 | $23,000 | -8.0% | 1,100 | 0.0% | 0.00% | – |
| Q3 2021 | $25,000 | -66.7% | 1,100 | -63.7% | 0.00% | – |
| Q2 2021 | $75,000 | -35.3% | 3,031 | -24.2% | 0.00% | – |
| Q1 2021 | $116,000 | +510.5% | 4,000 | +433.3% | 0.00% | – |
| Q2 2020 | $19,000 | +18.8% | 750 | 0.0% | 0.00% | – |
| Q1 2020 | $16,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 1,621,829 | $75,723,196 | 32.88% |
| COMMODORE CAPITAL LP | 1,675,000 | $78,205,750 | 8.79% |
| Ghost Tree Capital, LLC | 360,000 | $16,808,400 | 5.55% |
| Boxer Capital, LLC | 1,676,733 | $78,287 | 3.63% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 241,357 | $11,268,958 | 3.49% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $27,745,579 | 3.45% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 236,500 | $11,039,820 | 3.42% |
| Logos Global Management LP | 520,000 | $24,278,800 | 3.30% |
| Redmile Group, LLC | 1,811,672 | $84,586,966 | 3.25% |
| Yiheng Capital Management, L.P. | 1,201,591 | $56,102,284 | 3.03% |